ING Think has published an analysis under the headline "Transformative or overhyped? The impact of weight-loss drugs on European food demand," marking the first explicit European-sector examination from a major bank's economic research desk.

The bank's editorial framing carries weight. By titling the piece "transformative or overhyped," ING positions the impact as a probability question rather than a directional call. That signals measured uncertainty rather than a thematic conviction, and it sets a benchmark tone for how European operators and investors should price the demand risk over the next 24 months.

European hospitality is directly exposed to whatever the answer turns out to be. Out-of-home consumption runs on basket attachment — drinks, sides, desserts and impulse add-ons — and any sustained reduction in per-cover calorie intake compresses revenue mix even when footfall holds. Restaurant, bakery-café and QSR operators with high exposure to sweet and snack categories face the most acute read-through.

What does ING Think's framing signal?

The "transformative versus overhyped" construct is the standard device analysts use when evidence is incomplete but the strategic question cannot be deferred. ING's economists are stress-testing demand rather than forecasting a number. For operators, the practical value lies in the scenario set, not in a single point estimate.

The US precedent makes the stakes concrete. Packaged-food majors have already reported softer volumes in snack, confectionery and impulse categories through 2024 and 2025, with management commentary explicitly citing GLP-1-using cohorts in several earnings calls. European penetration lags the US on reimbursement and prescription access, which lengthens the runway but does not eliminate the eventual hit.

Which European hospitality categories sit in the firing line?

The exposure map divides cleanly by menu mix:

• Bakery-cafés, ice cream operators and sweet-bakery concepts: highest direct exposure, given that impulse and dessert attach drives a disproportionate share of margin
• Standard QSR with sugary beverage attachment and bundled combo meals: moderate exposure, partially offset by protein-forward menu extensions
• Full-service restaurants with per-cover beverage and digestif programmes: lower exposure but worth a mix review
• Protein-forward, health-positioned concepts: relative beneficiary, with potential tailwind in substitution traffic

Hotel F&B programmes — breakfast buffet attach, minibar and room-service mix — sit on the periphery but warrant the same category review.

What should operators do now?

Three workstreams follow from ING's framing. First, segment loyalty and transaction data by basket composition to baseline the most exposed categories. Second, accelerate protein-forward and portion-flexible menu work that hedges either outcome. Third, watch reimbursement and prescription-rate disclosures from national health systems, which are the leading indicator for European penetration timing.

What happens next?

ING Think's analysis is the opening move. Comparable notes from other major research desks — and the first European-specific penetration data — are expected to follow through Q4 2025, sharpening the picture before any 2026 budget cycle.